Friday, June 26, 2026
41.8 C
New Delhi

Maruti Suzuki shares jump 4% after Q4 results. What Jefferies, Goldman Sachs and HSBC recommend now

It added that demand momentum remains healthy despite geopolitical concerns, while the outlook for exports is balanced despite Middle East logistics issues.
It added that demand momentum remains healthy despite geopolitical concerns, while the outlook for exports is balanced despite Middle East logistics issues.

Shares of Maruti Suzuki India Limited (MSIL), India’s largest passenger carmaker, rallied over 4 per cent to their day’s high of ₹13,441 on the BSE on Wednesday after it reported a 7 per cent year-on-year (YoY) decline in standalone profit for the March quarter at ₹3,591 crore, compared with ₹3,857 crore in the same period last year.

Revenue from operations for Q4FY26 rose 28 per cent to ₹2,449 crore, up from ₹40,910 crore in the corresponding quarter of the previous financial year. The company’s profit after tax came in below Street estimates of ₹4,279 crore, while revenue exceeded analyst expectations of ₹51,486 crore.

Maruti Suzuki posted its highest-ever quarterly sales at 6,76,209 units, marking an 11.8 per cent increase from Q4 FY2024-25. Domestic sales stood at 538,994 units, while exports reached a record 137,215 units. For the full financial year FY2025-26, MSIL reported its highest-ever net profit of Rs 14,445 crore, compared with ₹14,298 crore in the previous year.

Maruti Suzuki shares: Should you buy?
Jefferies has maintained its Hold rating on Maruti Suzuki with a target price of ₹13,800 (7 per cent upside). However, the brokerage flagged that Maruti Suzuki’s market share has slipped to a 13-year low amid a shift in demand toward SUVs, which remains a concern. Following the recent correction, the stock is trading at 24x FY27E PE, compared with its 10-year average of 26x. Jefferies has cut its FY27–28E EPS estimates by 9 per cent.

Goldman Sachs has maintained its Buy rating on Maruti Suzuki with a target price of ₹15,800. The brokerage said fourth-quarter results were broadly in line with expectations, while domestic volume growth guidance of 10 per cent for FY27 was positive. It also noted that channel inventory remains lean at around 12 days.

It added that demand momentum remains healthy despite geopolitical concerns, while the outlook for exports is balanced despite Middle East logistics issues. Several high-demand models continue to face supply constraints.

Morgan Stanley has maintained its Overweight rating on Maruti Suzuki with a target price of Rs 17,895 and has taken a tactical buy view on the stock. The price implies an upside potential of 39 per cent from current levels. The brokerage expects near-term outperformance over the next 30 days.

It believes margins are likely to bottom out in Q1FY27 and recover thereafter. The brokerage said operating leverage, lower discounts, and a richer product mix should help support margins going forward. It also pointed out that valuations are currently below long-term averages. Morgan Stanley has assigned a 70-80 per cent probability to its positive scenario for the stock.

HSBC has maintained its Buy rating on Maruti Suzuki with a target price of ₹15,000. The brokerage said the company reported an in-line fourth quarter and has so far managed commodity inflation effectively. It added that management’s 10 per cent volume growth guidance for FY27 was encouraging and reflects a resilient demand environment. HSBC also noted that valuations at 20x FY28E EPS appear reasonable, while Maruti Suzuki is expected to be a key beneficiary of the 8th Pay Commission.

Motilal Oswal has maintained its Buy rating on Maruti while cutting its target price to Rs 15,529, implying an upside potential of 20 per cent. The brokerage said the recent GST rate cut has helped revive demand for small cars, making vehicles more affordable for price-sensitive buyers.

The firm noted that Maruti currently has a strong order backlog of 190,000 units. Supported by this pending demand and a healthy pipeline of new launches, management remains confident of delivering 10 per cent domestic volume growth in FY27E, which is expected to support market share recovery. The brokerage believes this improvement in volumes and market share could lead to a re-rating of the stock.

  • Published On Apr 29, 2026 at 09:58 AM IST

Join the community of 2M+ industry professionals.

Subscribe to Newsletter to get latest insights & analysis in your inbox.

All about ETAuto industry right on your smartphone!

Go to Source

Hot this week

King Charles reveals £12.9m tax bill for first time as monarchy’s public funding nears £100m

King Charles makes historic tax disclosure as Royal public funding approaches £100m / Image – file Britain’s royal finances have entered a new era of transparency after King Charles became the first reigning monarch to Read More

Sickle cell breakthrough: World’s first CRISPR therapy cures Louisiana man’s lifelong disease

A 23-year-old man from Louisiana has become one of the first people in the United States to be functionally cured of sickle cell disease using Casgevy, the world’s first approved CRISPR-based gene-editing therapy. Read More

Italy’s electoral rules may change before polls: Why Meloni’s proposal has triggered row

Italian Prime Minister Giorgia Meloni is pushing ahead with a sweeping overhaul of the country’s electoral system, a move that opposition parties have condemned as an “authoritarian” attempt to tilt next year’s Read More

Is France equipped to handle heatwaves? 55 drown from swimming in unauthorised locations

A gruelling heatwave has embroiled France, leading to 55 deaths through drowning. Read More

For first time, names of soldiers martyred during Operation Sindoor made public

The identities of six Indian armed forces personnel who laid down their lives during Operation Sindoor have been made public for the first time NEW DELHI: The identities of six Indian armed forces personnel who laid down their lives Read More

Topics

King Charles reveals £12.9m tax bill for first time as monarchy’s public funding nears £100m

King Charles makes historic tax disclosure as Royal public funding approaches £100m / Image – file Britain’s royal finances have entered a new era of transparency after King Charles became the first reigning monarch to Read More

Sickle cell breakthrough: World’s first CRISPR therapy cures Louisiana man’s lifelong disease

A 23-year-old man from Louisiana has become one of the first people in the United States to be functionally cured of sickle cell disease using Casgevy, the world’s first approved CRISPR-based gene-editing therapy. Read More

Italy’s electoral rules may change before polls: Why Meloni’s proposal has triggered row

Italian Prime Minister Giorgia Meloni is pushing ahead with a sweeping overhaul of the country’s electoral system, a move that opposition parties have condemned as an “authoritarian” attempt to tilt next year’s Read More

Is France equipped to handle heatwaves? 55 drown from swimming in unauthorised locations

A gruelling heatwave has embroiled France, leading to 55 deaths through drowning. Read More

For first time, names of soldiers martyred during Operation Sindoor made public

The identities of six Indian armed forces personnel who laid down their lives during Operation Sindoor have been made public for the first time NEW DELHI: The identities of six Indian armed forces personnel who laid down their lives Read More

Wedding Tuxedos: The Perfect Blend Of Elegance And Confidence

Getting married is one of the most significant moments in a man’s life, and they aim to be the most appropriately dressed. Even as wedding fashions change with time, there is one particular attire that will always remain relevant- the wedding suit. Read More

‘Actors charge Rs 50-100 crore, Bachchan paid for his own spot boy, make-up’

One often hears a discussion on the entourage costs of big stars and how it adds a burden on the produer. In a recent interview, veteran producer KC Bokadia has slammed actors who charge big money for a film and their teams. Read More

‘Was so angry and jealous of Tabu for winning the National award,’ recalls Sonali Kulkarni

Tabu is known for being one of the best actresses in Hindi cinema, who has won several awards along with critical acclaim, also including the National Award. Read More

Related Articles